Abstract
Neuron-specific γ-enolase in human neurogenic tumors, including gliomas, transplanted gliomas, and permanent human glioma cell lines, was studied quantitatively, using newly established enzyme immunoassay methods, together with immunostaining of the tissue and cell preparations. A significantly high level of γ-enolase was found in some glioblastomas, astrocytomas and oligodendrogliomas as well as medulloblastomas. Glioblastomas transplanted into mice and cultured cell lines derived from the same origins, as well as the permanent human glioma cell lines, also contained γ-enolase, although the contents were low compared with findings in the original tumor tissues. Immunohistochemically, γ-enolase stained intensely in the glioblastomatous cells. Serum γ-enolase concentrations in some patients with gliomas and those of all the transplanted mice were enhanced. The serum γ-enolase levels in the mice correlated well with size of the transplanted tumor tissues. These results indicate that neuron-specific γ-enolase is produced in some neurogenic tumors of nonneuronal origin, therefore, serum γ-enolase may be a useful biomarker for monitoring the extent of disease in patients with gliomas.
Similar content being viewed by others
References
Ariyoshi Y., Kato K., Ishiguro Y., Ohta K., Sato T., and Suchi T. (1983) Evaluation of human neuron-specific enolase as a tumor marker for carcinoma of the lung.Gann 74, 219–225.
Bonnin J. M., Rubinstein L. J., Papasozomenos S. C., and Maragos P. J. (1984) Subependymal giant cell astrocytoma, Significance and possible cytogenetic implications of an immunohistochemical study.Acta Neuropathol. 62, 185–193.
Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal. Biochem. 7, 248–254.
Carney D. N., Marangos P. J., Daniel C. I., Paul Jr., A. B., Martin H. C., Johon D. M., and Gazdar A. (1982) Serum neuron specific enolase: A marker for disease extent and response to therapy of small cell lung cancer.Lancet I, 583–595.
Fletcher L., Rider C. C., and Taylor C. B. (1976) III Enolase Enzymes. Chromatographic and immunological characteristics of brain enolase.Biochem. Biophys. Acta 452, 245–252.
Haimoto H., Takahashi Y., Koshikawa T., Nagura H., and Kato K. (1985) Immunohistochemical localization of γ-enolase in normal human tissues other than nervous and neuroendocrine tissues.Lab. Invest. 52, 257–263.
Ishiguro Y., Kato K., Shimizu A., Ito T., and Nagaya M. (1982) High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma.Clin. Chim. Acta 121, 173–180.
Kato K., Fukui H., Hamaguchi Y., and Ishikawa E. (1976) Enzyme-Linked Immunoassay: Conjugation of the Fab’ fragment of rabbit IgG with beta-D-galactosidase fromE. coli and its use for immunoassay.J. Immunol. 116, 1554–1560.
Kato K., Higashida H., Umeda Y., Suzuki F., and Tanaka T. (1981) Regulation of neuron-specific enolase in NG 108-15 hybrid cells and C6BU-1 glioma cells.Biochim. Biophys. Acta 660, 30–35.
Kato K., Ishiguro Y., and Ariyoshi Y. (1983a) Enolase isozymes as disease markers: Distribution of three enolase subunits (α, β and γ) in various human tissues.Dis. Markers 1, 213–220.
Kato K., Okagawa Y., Suzuki F., Shimizu A., Mokuno K., and Takahashi Y. (1983b) Immunoassay of human muscle enolase in serum: A novel marker antigen for muscle disease.Clin. Chim. Acta 131, 75–85.
Kato K., Asai R., Shimizu A., Suzuki F., and Ariyoshi Y. (1983c) Immunoassay of three enolase isozymes in human serum and in blood cells.Clin. Chim. Acta 127, 353–363.
Mannoji H., Takeshhita I., Fukui M., Ohta M., and Kitamura K. (1981) Glial fibrillary acidic protein in medulloblastoma.Acta Neuropathol. (Berl)55, 63–69.
Ponten J. and Weatermark B. (1978) Properties of human malignant glioma cells in vitro.Med. Biol. 56, 184–193.
Rider C. C. and Taylor C. B. (1974) Enolase isoenzymes in rat tissue: Electrophoretic, chromatographic, immunological and kinetic properties.Biochim. Biophys. Acta 365, 285–350.
Schmechel D. E., Marangos P. J., Brightman M., and Goodwin F. K. (1978a) The brain enolase as specific markers of neuronal and glial cells.Science 199, 313–315.
Schmechel D. E., Marangos P. J., and Brightman M. W. (1978b) Neuron-specific enolase is a molecular marker for peripheral and central neuroendocrine cells.Nature 276, 834–836.
Schmechel D. E., Brightman M. W., and Marangos P. J. (1980) Neurons swich from non-neuronal enolase to neuron-specific enolase during differentiation.Brain Res. 190, 195–214.
Schmechel D. E. (1985) γ-subunit of the glycolytic enzyme enolase: Non-specific or neuron specific?Lab. Invest. 52, 3, 239.
Shimizu A., Suzuki F., and Kato K. (1982) Purification of two enolases from human brain using a chromatofocusing column.Biochim. Biophys. Acta 717, 348–354.
Stanley A. V., Bonnin J. M., Rubinstein L. J., and Marangos P. J. (1984) Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues.Arch. Pathol. Lab. Med. 108, 536–540.
Sternberger L. A., Hordy, Jr. P. H., and Cuculis J. J. (1970) The unlabeled antibody-enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.J. Histochem. Cytochem. 18, 315–333.
Takeshita I., Bigner S., Liou J., Brown O. E., Sedwick D., and Bigner D. D. (1981) A thymidine kinase (TK) deficient 5-bromodeoxyuridine (BUdR) resistant human glioma (HGL)-derived permanent cell line that expresses glial fibrillary acidic protein (GFAP).J. Neuropathol. Exp. Neurol. 40, 336.
Tapia F. J., Polak J. M., Barbosa A. J. A., Bloom S. R., Marangos P. J., Dermody C., and Pearse A. G. E. (1981) Neuron specific enolase is produced by neuroendocrine tumors.Lancet 1, 808–811.
Yamashita M., Takeshita I., and Kitamura K. (1978) Heterotransplantation of human glioma in hereditary asplenic athyrmic mouse.Gann 69, 735–736.
Yamashita M., Takeshita I., Mannoji H., Ohta M., and Kitamura K. (1981) Establishment and maintenance of a human glioma transplanted serially into hereditary asplenic athymic (Lasat) mice.Exp. Cell. Biol. 49, 41–53.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuramitsu, M., Sawa, H., Takeshita, I. et al. Neuron-specific γ-enolase derived from human glioma. Neurochemical Pathology 4, 89–105 (1986). https://doi.org/10.1007/BF03160188
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03160188